Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

People with alopecia areata may have a higher risk of blood clots.

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Men with alopecia areata have different body fat distribution compared to healthy men.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

A 5-year-old boy's seasonal hair loss is linked to his allergies.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Men with alopecia areata tend to have larger limb and trunk circumferences than healthy men.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Aging causes changes in the scalp that can affect hair growth and lead to older-looking hair in women.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.